Study Stopped
Stopped for lack of funds
Endothelial Cell Loss After Cataract Surgery
1 other identifier
interventional
39
1 country
1
Brief Summary
The purpose of this study is to compare two cataract surgical technique variations for removing the nucleus of the lens (central part of the lens) in terms of damage to the inner layer of the cornea which is called the endothelium. One variation uses more ultrasound energy and the other more mechanical force to break up the nucleus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Jul 2009
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2009
CompletedStudy Start
First participant enrolled
July 1, 2009
CompletedFirst Posted
Study publicly available on registry
July 3, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2012
CompletedAugust 25, 2014
August 1, 2014
3 years
July 1, 2009
August 21, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Corneal endothelial cell loss by specular microscopy after cataract surgery
3 months post-operatively
Study Arms (2)
Ultrasound phacoemulsification
ACTIVE COMPARATORCataract nucleus is removed using standard amounts of ultrasound energy.
Reduced ultrasound phacoemulsification
ACTIVE COMPARATORCataract nucleus removal using less ultrasound energy and more mechanical energy.
Interventions
Cataract nucleus removal using standard amounts of ultrasound energy
Cataract nucleus removal using less ultrasound energy and more mechanical energy.
Eligibility Criteria
You may qualify if:
- Visually significant moderate density cataract
You may not qualify if:
- Corneal or retinal pathology limiting visual potential to worse than 20/40
- Lens pathology including pseudoexfoliation or lens dislocation
- Prior intraocular surgery
- Age less than 40
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California San Francisco
San Francisco, California, 94143, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Hwang, MD
University of California, San Francisco
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 1, 2009
First Posted
July 3, 2009
Study Start
July 1, 2009
Primary Completion
July 1, 2012
Study Completion
July 1, 2012
Last Updated
August 25, 2014
Record last verified: 2014-08